AJR Get Involved! Join ARRS Today
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bartolozzi, C.
Right arrow Articles by Ciancia, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bartolozzi, C.
Right arrow Articles by Ciancia, E. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

American Journal of Roentgenology, Vol 162, 827-831, Copyright © 1994 by American Roentgen Ray Society

ARTICLES

Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging

C Bartolozzi, R Lencioni, D Caramella, S Mazzeo and EM Ciancia
Department of Radiology, University of Pisa, Italy.

OBJECTIVE. The aim of this study was to investigate the usefulness of unenhanced and enhanced MR imaging in evaluating the response of hepatocellular carcinoma to percutaneous injection of ethanol. SUBJECTS AND METHODS. Thirty-one patients with 40 hepatocellular carcinomas less than 5 cm in diameter were examined with MR imaging before and after percutaneous injection of ethanol. Unenhanced T1- and T2-weighted and contrast-enhanced T1-weighted spin-echo images were obtained. CT and percutaneous biopsy were performed 1 month after the final injection of ethanol and repeated at 6-month intervals to establish the outcome of treatment: complete tumor necrosis was shown in 36 lesions and incomplete tumor necrosis was seen in four lesions. RESULTS. Of the 36 proved necrotic lesions, 31 showed homogeneously low signal intensity on T2-weighted MR images obtained after treatment, owing to coagulative necrosis of the tumor. In the remaining five necrotic lesions, hypointense and hyperintense areas coexisted; the hyperintense areas were caused by liquefactive necrotic material in two cases and by chronic inflammatory tissue along the boundary of the necrotic area in three cases. None of the 36 necrotic lesions showed contrast enhancement on T1-weighted images obtained after IV injection of gadopentetate dimeglumine. In the four lesions with incomplete necrosis, the viable portion of the tumor was identified as a hyperintense area on T2-weighted images and as an enhancing area on contrast-enhanced T1-weighted images. No correlation was found between lesion features on unenhanced T1-weighted images and outcome of therapy. CONCLUSION. Contrast-enhanced T1-weighted MR images allow a reliable evaluation of the effectiveness of treatment and are more accurate than unenhanced MR studies. Contrast-enhanced MR imaging may be considered a valuable alternative to contrast-enhanced CT in the follow-up of hepatocellular carcinomas treated with percutaneous injection of ethanol.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
S. Colagrande, M. L. Paolucci, L. Messerini, W. Schima, A. Stadler, T. V. Bartolotta, A. Vanzulli, and G. Brancatelli
Solitary Necrotic Nodules of the Liver: Cross-Sectional Imaging Findings and Follow-Up in Nine Patients
Am. J. Roentgenol., October 1, 2008; 191(4): 1122 - 1128.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
E. Liapi and J.-F. H. Geschwind
Transcatheter and Ablative Therapeutic Approaches for Solid Malignancies
J. Clin. Oncol., March 10, 2007; 25(8): 978 - 986.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
A. L. Keppke, R. Salem, D. Reddy, J. Huang, J. Jin, A. C. Larson, and F. H. Miller
Imaging of Hepatocellular Carcinoma After Treatment with Yttrium-90 Microspheres
Am. J. Roentgenol., March 1, 2007; 188(3): 768 - 775.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
P. V. Pandharipande, G. A. Krinsky, H. Rusinek, and V. S. Lee
Perfusion Imaging of the Liver: Current Challenges and Future Goals
Radiology, March 1, 2005; 234(3): 661 - 673.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
M. W. Wilson, R. K. Kerlan Jr, N. A. Fidelman, A. P. Venook, J. M. LaBerge, J. Koda, and R. L. Gordon
Hepatocellular Carcinoma: Regional Therapy with a Magnetic Targeted Carrier Bound to Doxorubicin in a Dual MR Imaging/ Conventional Angiography Suite--Initial Experience with Four Patients
Radiology, January 1, 2004; 230(1): 287 - 293.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
S. K. Kim, H. K. Lim, Y. H. Kim, W. J. Lee, S. J. Lee, S. H. Kim, J. H. Lim, and S. A. Kim
Hepatocellular Carcinoma Treated with Radio-frequency Ablation: Spectrum of Imaging Findings
RadioGraphics, January 1, 2003; 23(1): 107 - 121.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
C. Dromain, T. de Baere, D. Elias, V. Kuoch, M. Ducreux, V. Boige, P. Petrow, A. Roche, and R. Sigal
Hepatic Tumors Treated with Percutaneous Radio-frequency Ablation: CT and MR Imaging Follow-up
Radiology, April 1, 2002; 223(1): 255 - 262.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Roentgen Ray Society.